The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Dr Stephen Barnhill........
https://www.openaccessgovernment.org/medical-cannabis-cancer-treatments/131741/
Apollon Formularies
@apollon_uk
·
58m
#APOL's goal is to reposition Jamaica's medical cannabis industry, in terms of science, research & development, product manufacturing, affordable patient care, and legal export, while becoming an industry leader in the global pharmaceutical & nutraceutical medical cannabis space
Apollon Formularies
@apollon_uk
·
7m
#Apollon was very pleased to announce its signing of tripartite agreements with local Jamaican farmers which will be mutually beneficial for both parties: creating a constant supply of #cannabis for $APOL & supporting traditional growers whilst also providing new opportunities
Apollon Formularies
@apollon_uk
·
4h
"These #APOL formulation test results on prostate cancer and the plan to immediately begin treatments in Jamaica are extremely exciting developments, in part, because traditional chemotherapy, radiation, and surgery cancer treatment protocols are expensive"
https://twitter.com/apollon_uk
the revenue is selling in the retail market place and once this is achieved i expect the sp to start motoring. if then is replicated in other regions its worth a huge amount. this is the change thats needed
REC.......... Just spotted it.............
https://twitter.com/apollon_uk/status/1502222937721827332
#Apollon has an active year ahead, in which the Company hopes to progress patenting on several of its medical cannabis formulations. $APOL is also seeking Jamaican Regulatory Authority to allow for wide scale dispensary sales in hundreds of Jamaican pharmacies under prescription
Thanks Troajan good news....................
44 views
https://www.youtube.com/watch?v=l_hJaN747dU
Apollon Formularies
@apollon_uk
·
1h
The Joint Venture will be mutually beneficial, with Tri-Medi Canna gaining access to Apollon's vast experience across the value chain, from skill transfers in extraction and processing, pharmaceutical level drug development, clinical trials, patient treatment centres
https://twitter.com/apollon_uk
Hit the news....................
https://africabusinesscommunities.com/health-industry/news/apollon-formularies-establishes-joint-venture-with-tri-medi-canna-south-africa/
https://trimedicanna.co.za/tri-medi-canna-team/dr-ayanda-vilakazi/
https://www.youtube.com/watch?v=K9gfHwYX3I4
https://www.youtube.com/watch?v=ScNGXpLKoHk
Copy all and paste for location in SA...........
https://www.google.co.uk/maps/@-26.0980883,28.0909918,3a,15y,151.05h,98.98t/data=!3m6!1e1!3m4!1sgK2vpaalPBHZGf0WX1cNdw!2e0!7i13312!8i6656
Apollon Formularies
@apollon_uk
·
2h
(4/4) The JV will be mutually beneficial: Tri-Medi Canna will gain access to #APOL’s experience, including skill transfers in extraction & processing, experienced #medicalcannabis physicians, & the exclusive distribution of $APOL products & formulations after necessary licensing
Apollon Formularies
@apollon_uk
·
44m
"This is a major step forward in Apollon's plans to reach global markets and the African market which still remains largely untapped."
Stene Jacobs, COO
Apollon Formularies strikes out for the first time internationally as it teams up with South African cannabis company
https://www.proactiveinvestors.co.uk/companies/news/975509/apollon-formularies-strikes-out-for-the-fist-time-internationally-as-it-teams-up-with-south-african-cannabis-company-975509.html
this is so far off the radar of investors it will take revenue and profit being the only things to shift sp
Interesting to read about them here. There will be huge support and many in work from this venture. Also read about project.
https://trimedicanna.co.za/
https://trimedicanna.co.za/about-tri-medi-canna/
https://www.investegate.co.uk/apollon-formularies--apol-/rns/joint-venture-with-tri-medi-canna--south-africa/202203020700082913D/
That's more like it...... Will hopefully be a positive reaction to this news.
Apollon Formularies
@apollon_uk
·
50m
"As part of independent laboratory testing, we demonstrated that, when #APOL medical cannabis formulations are used together with Aion's medicinal mushroom formulations, nearly 100% of HER2+ breast cancer cells in 3D cell culture are killed through multiple different pathways"
Apollon Formularies
@apollon_uk
·
1h
In addition to its new Cancer Institute in Kingston, Apollon also has its Negril facility, which has been in use since 2015. As well as being the site for the Company's R&D and processing lab and dispensary, the facility has treated over 400 patients in the last 24 months
$APOL